Skip to main navigation Skip to search Skip to main content

Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma

  • Hervé Avet-Loiseau
  • , Rafael Fonseca
  • , David Siegel
  • , Meletios A. Dimopoulos
  • , Ivan Špička
  • , Tamás Masszi
  • , Roman Hájek
  • , Laura Rosiñol
  • , Vesselina Goranova-Marinova
  • , Georgi Mihaylov
  • , Vladimír Maisnar
  • , Maria Victoria Mateos
  • , Michael Wang
  • , Ruben Niesvizky
  • , Albert Oriol
  • , Andrzej Jakubowiak
  • , Jiri Minarik
  • , Antonio Palumbo
  • , William Bensinger
  • , Vishal Kukreti
    • Dina Ben-Yehuda, A. Keith Stewart, Mihaela Obreja, Philippe Moreau

Hackensack Meridian School of Medicine

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Biochemistry, Genetics and Molecular Biology